Puma Biotechnology Prices Public Offering of Common Stock

[Business Wire] – Puma Biotechnology, Inc. , a development stage biopharmaceutical company, announced the pricing of an underwritten public offering of 979,592 shares of its common stock at $122.50 per share. more

View todays social media effects on PBYI

View the latest stocks trending across Twitter. Click to view dashboard

See who Puma is hiring next, click here to view